Key statistics
On Monday, TScan Therapeutics Inc (TCRX:NMQ) closed at 5.50, 92.31% above the 52 week low of 2.86 set on Oct 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.51 |
---|---|
High | 5.51 |
Low | 5.33 |
Bid | 4.90 |
Offer | 5.65 |
Previous close | 5.51 |
Average volume | 254.14k |
---|---|
Shares outstanding | 52.97m |
Free float | 48.27m |
P/E (TTM) | -- |
Market cap | 291.89m USD |
EPS (TTM) | -1.05 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Announcements
- TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting
- TScan Therapeutics to Participate in Upcoming Investor Conferences
- TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- TScan Therapeutics Announces Updates to its Board of Directors
- TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
- TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
- TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
- TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
- TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
- TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
More ▼